Evolution and persistence of resistance-associated substitutions of hepatitis c virus after daclatasvir plus asunaprevir treatment failures

被引：0
作者：
Jeong, Y. [1 ,2 ]
Jin, B. [1 ,2 ]
Lee, H. W. [1 ]
Park, H. J. [1 ]
Kim, D. Y. [1 ]
Han, K. -H. [1 ]
Kim, S. [1 ]
Ahn, S. H. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea
[2] Yonsei Univ, Brain Korea 21 Plus Project Med Sci, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)31826-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-381
引用
收藏
页码：S779 / S780
页数：2
相关论文
共 50 条
  • [21] Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection
    Dietz, Julia
    Kalinina, Olga, V
    Vermehren, Johannes
    Peiffer, Kai-Henrik
    Matschenz, Katrin
    Buggisch, Peter
    Niederau, Claus
    Schattenberg, Jorn M.
    Muellhaupt, Beat
    Yerly, Sabine
    Ringelhan, Marc
    Schmid, Roland M.
    Antoni, Christoph
    Mueller, Tobias
    zur Wiesch, Julian Schulze
    Piecha, Felix
    Moradpour, Darius
    Deterding, Katja
    Wedemeyer, Heiner
    Moreno, Christophe
    Berg, Thomas
    Berg, Christoph P.
    Zeuzem, Stefan
    Welsch, Christoph
    Sarrazin, Christoph
    [J]. JOURNAL OF VIRAL HEPATITIS, 2020, 27 (10) : 974 - 986
  • [22] Prevalence of resistance-associated substitutions and phylogenetic analysis of hepatitis C virus infection in Russia
    Isakov, Vasily
    Hedskog, Charlotte
    Wertheim, Joel O.
    Hostager, Reilly E.
    Parhy, Bandita
    Schneider, Adriano De Bernardi
    Suri, Vithika
    Mo, Hongmei
    Geivandova, Natalia
    Morozov, Vyacheslav
    Bessonova, Elena
    Gankina, Natalya
    Zhdanov, Konstantin
    Abdurakhmanov, Dzhamal
    Svarovskaia, Evguenia
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 36 - 42
  • [23] Resistance Analysis of Hepatitis C Virus Genotype 1 Prior Treatment Null Responders Receiving Daclatasvir and Asunaprevir
    McPhee, Fiona
    Hernandez, Dennis
    Yu, Fei
    Ueland, Joseph
    Monikowski, Aaron
    Carifa, Arlene
    Falk, Paul
    Wang, Chunfu
    Fridell, Robert
    Eley, Timothy
    Zhou, Nannan
    Gardiner, David
    [J]. HEPATOLOGY, 2013, 58 (03) : 902 - 911
  • [24] Daclatasvir plus asunaprevir in treatment-naive patients with hepatitis C virus genotype 1b infection
    Wei, Lai
    Wang, Fu-Sheng
    Zhang, Ming-Xiang
    Jia, Ji-Dong
    Yakovlev, Alexey A.
    Xie, Wen
    Burnevich, Eduard
    Niu, Jun-Qi
    Jung, Yong Jin
    Jiang, Xiang-Jun
    Xu, Min
    Chen, Xin-Yue
    Xie, Qing
    Li, Jun
    Hou, Jin-Lin
    Tang, Hong
    Dou, Xiao-Guang
    Gandhi, Yash
    Hu, Wen-Hua
    McPhee, Fiona
    Noviello, Stephanie
    Treitel, Michelle
    Mo, Ling
    Deng, Jun
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (12) : 1361 - 1372
  • [25] Editorial: glecaprevir/pibrentasvir for the treatment of hepatitis C virus-do baseline resistance-associated substitutions matter?
    Kwong, Allison J.
    Kwo, Paul Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (07) : 739 - 740
  • [26] ANALYSIS OF BUDGETARY IMPACT OF THE USE OF DACLATASVIR plus ASUNAPREVIR IN THE TREATMENT OF PATIENTS WITH HEPATITIS C IN COLOMBIA
    Romero Prada, M. E.
    Marrugo Figueroa, R. D.
    Acero Acero, G.
    Alfonso Quinones, P. A.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A869 - A869
  • [27] Molecular characterization of Hepatitis C virus resistance-associated substitutions after interferon-free treatment failure by massive parallel sequencing
    Chen, Q.
    Perales, C.
    Crespo, J.
    Buti, M.
    Calleja, J. L.
    Gregori, J.
    Rodriguez-Frias, F.
    Nieto, L.
    Niubo, J.
    Rodriguez, M.
    Conde, I.
    Buey, M. L. G.
    Fernandez, I.
    Torras, J.
    Morillas, R.
    Diago, M.
    Saez-Royuela, F.
    Forne, M.
    Tunes, J.
    Samaniego, J. G.
    Carrion, J. A.
    Arenas, J. I.
    Forns, X.
    Marino, Z.
    Andrade, R.
    Montoliu, S.
    Simon, M. A.
    Antolin, G. S.
    Sanchez-Ruano, J. J.
    Pascasio, J. M.
    Esteban, J. I.
    Quer, J.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S731 - S731
  • [28] Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response
    Hong, Chun-Ming
    Liu, Chun-Jen
    Yeh, Shiou-Hwei
    Chen, Pei-Jer
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (04) : 295 - 299
  • [29] Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus
    Lee, Wei-Ping
    Lan, Keng-Li
    Liao, Shi-Xian
    Huang, Yi-Hsiang
    Hou, Ming-Chih
    Lan, Keng-Hsin
    [J]. AMERICAN JOURNAL OF CHINESE MEDICINE, 2018, 46 (04): : 835 - 852
  • [30] Direct-Acting Antiviral Treatment Failures and Resistance Associated Substitutions in Hepatitis C Virus Infection in Ireland
    Kelly, Abbie
    Dean, Jonathan
    O'Leary, Aisling
    Stewart, Stephen
    Feeney, Eoin
    Kelleher, Barry
    McKiernan, Susan Mary
    McCormick, P. Aiden
    Murray, Frank E.
    Crosbie, Orla M.
    Houlihan, Diarmuid
    Bergin, Colm
    Fanning, Liam J.
    Norris, Suzanne
    Lambert, Jack
    McConkey, Sam
    Courtney, Garry
    Lee, John
    De Gascun, Cillian
    [J]. HEPATOLOGY, 2018, 68 : 406A - 407A
12345